Skip to content
★ Sign in to follow
AB

Allan Bombard

Sequenom Inc
Total declarations
13
Company
1
▲ Purchases (2 ops.)
€40k
▼ Sales (0 ops.)
—

Latest filing published 12 Feb 2014 for SEQUENOM INC.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Allan Bombard: trading record in brief

Allan Bombard appears in our data through filings on Sequenom Inc shares, published by SEC (Form 4). We count 13 filings; the first trade dates from 13 August 2010 and the latest from 10 February 2014.

Every open-market trade on record is a purchase: 2 purchases worth €40k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 11 share grants.

The newest entry dates from 12 February 2014: a share grant of €5,637, in Sequenom Inc. The clock since the last published purchase (13 December 2011) now reads 5,445 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Allan Bombard

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    7,475 shares0Common StockSEC:0001182615-14-000040:0
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    7,678 USD0SEC
    3,281 shares@ US$2.34Common StockSEC:0001182615-14-000040:1
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    11,666 shares0Common StockSEC:0001321466-13-000084:0
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    18,505 USD0SEC
    4,385 shares@ US$4.22Common StockSEC:0001321466-13-000084:1
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    1,555 shares0Common StockSEC:0001454522-12-000011:0
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    3,203 USD0SEC
    651 shares@ US$4.92Common StockSEC:0001454522-12-000011:1
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    1,555 shares0Common StockSEC:0001454522-12-000011:2
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    390 shares0Common StockSEC:0001454522-12-000011:4
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    802 USD0SEC
    163 shares@ US$4.92Common StockSEC:0001454522-12-000011:5
  • ▲
    Chief Medical OfficerExecutivesSequenom Inc
    27,510 USD0SEC
    7,000 shares@ US$3.93Common StockSEC:0001454522-11-000028:0
    Canonical exit: 11 Mar 2012 (T+90)
  • ◆
    Chief Medical OfficerExecutivesSequenom Inc
    0SEC
    1,944 shares0Common StockSEC:0001454522-11-000012:0
  • ▲
    Chief Medical OfficerExecutivesSequenom Inc
    24,940 USD0SEC
    4,345 shares@ US$5.74Common StockSEC:0001498278-10-000008:0
    Canonical exit: 11 Nov 2010 (T+90)

12 of 12 declarations